Chemical structure | Common name | Total | Participants without neuropathy | Participants with Primary open-angle glaucoma | P |
---|---|---|---|---|---|
Omega 6 | |||||
 C18:2 n-6 | Linoleic acid (LA) | 25.03 ± 3.87 | 25.04 ± 3.89 | 24.95 ± 3.68 | 0.854 |
 C18:3 n-6 | Gamma linoleic acid (GLA) | 0.45 ± 0.17 | 0.46 ± 0.17 | 0.43 ± 0.15 | 0.225 |
 C20:3 n-6 | Dihomo-gamma-linoleic acid (DGLA) | 1.53 ± 0.32 | 1.53 ± 0.32 | 1.55 ± 0.31 | 0.605 |
 C20:4 n-6 | Arachidonic acid (AA) | 7.46 ± 1.48 | 7.45 ± 1.47 | 7.54 ± 1.53 | 0.624 |
 C22:4 n-6 | Docosatetraenoic Acid (DTA) | 0.26 ± 0.07 | 0.25 ± 0.07 | 0.27 ± 0.10 | 0.164 |
 C22:5 n-6 | Docosapentaenoic n-6 (DPA) | 0.17 ± 0.05 | 0.17 ± 0.05 | 0.18 ± 0.06 | 0.148 |
Omega 3 | |||||
 C18:3 n-3 | Alpha linoleic acid (ALA) | 0.63 ± 0.21 | 0.63 ± 0.21 | 0.68 ± 0.25 | 0.065 |
 C20:5 n-3 | Eicosapentaenoic acid (EPA) | 1.29 ± 0.62 | 1.30 ± 0.64 | 1.13 ± 0.34 | 0.032 |
 C22:5 n-3 | Docosapentaenoic n-3 (DPA) | 0.59 ± 0.13 | 0.59 ± 0.13 | 0.59 ± 0.14 | 0.957 |
 C22:6 n-3 | Docosahexaenoic acid (DHA) | 2.22 ± 0.65 | 2.23 ± 0.66 | 2.15 ± 0.51 | 0.366 |
Sum | |||||
 Omega 6 |  | 35.15 ± 4.03 | 35.14 ± 4.08 | 35.22 ± 3.42 | 0.869 |
 Omega 3 |  | 4.74 ± 1.30 | 4.76 ± 1.33 | 4.56 ± 0.87 | 0.243 |
 Polyunsaturated fatty acids |  | 40.36 ± 4.18 | 40.37 ± 4.23 | 40.31 ± 3.63 | 0.916 |
Ratios | |||||
 LA/ALA |  | 43.43 ± 14.67 | 43.73 ± 14.92 | 40.12 ± 11.14 | 0.052 |
 Sum Omega 6 / Omega 3 |  | 7.90 ± 2.11 | 7.89 ± 2.15 | 7.97 ± 1.56 | 0.775 |